D-Index & Metrics Best Publications

Giuseppe Curigliano

University of Milan
Italy

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 87 Citations 32,199 751 World Ranking 8670 National Ranking 276

Overview

What is he best known for?

The fields of study Giuseppe Curigliano is best known for:

Cancer
Breast cancer
Chemotherapy

His Consensus conference research extends to Internal medicine, which is thematically connected. In his works, he conducts interdisciplinary research on Breast cancer and Metastatic breast cancer. He merges Metastatic breast cancer with Breast cancer in his study. He combines Oncology and Gastroenterology in his research. Giuseppe Curigliano integrates many fields, such as Gastroenterology and Internal medicine, in his works. Giuseppe Curigliano performs integrative Chemotherapy and Triple-negative breast cancer research in his work. His study deals with a combination of Triple-negative breast cancer and Chemotherapy. In his works, Giuseppe Curigliano conducts interdisciplinary research on Medical physics and Cancer. While working on this project, he studies both Family medicine and Gynecology.

His most cited work include:

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) (842 citations)
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) (697 citations)
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines (627 citations)

What are the main themes of his work throughout his whole career to date

Giuseppe Curigliano is investigating Metastatic breast cancer and Triple-negative breast cancer as part of his examination of Breast cancer. Giuseppe Curigliano merges Internal medicine with Gastroenterology in his research. Giuseppe Curigliano performs integrative study on Gastroenterology and Internal medicine in his works. His work often combines Chemotherapy and Breast cancer studies. He undertakes multidisciplinary investigations into Pathology and Oncology in his work. He integrates many fields in his works, including Surgery and Cancer. In his research, Giuseppe Curigliano undertakes multidisciplinary study on Intensive care medicine and Oncology. Giuseppe Curigliano connects Cancer research with Cancer in his study.

Giuseppe Curigliano most often published in these fields:

Internal medicine (96.04%)
Cancer (79.21%)
Oncology (76.24%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

A Goldhirsch;E P Winer;A S Coates;R D Gelber.
Annals of Oncology (2013)

3457 Citations

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

F. Cardoso;A. Costa;E. Senkus;M. Aapro.
Annals of Oncology (2017)

1313 Citations

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

Daniela Cardinale;Alessandro Colombo;Giulia Bacchiani;Ines Tedeschi.
Circulation (2015)

1128 Citations

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant.
Annals of Oncology (2017)

937 Citations

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

G. Curigliano;D. Cardinale;T. Suter;G. Plataniotis.
Annals of Oncology (2012)

844 Citations

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.

Rashmi K Murthy;Sherene Loi;Alicia Okines;Elisavet Paplomata.
The New England Journal of Medicine (2020)

610 Citations

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.

Humaid O. Al-Shamsi;Waleed Alhazzani;Ahmad Alhuraiji;Eric A. Coomes.
Oncologist (2020)

589 Citations

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell.
Advances in Anatomic Pathology (2017)

535 Citations

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell.
Advances in Anatomic Pathology (2017)

471 Citations

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Giuseppe Curigliano;Daniela Cardinale;Susan Dent;Carmen Criscitiello.
CA: A Cancer Journal for Clinicians (2016)

460 Citations

If you think any of the details on this page are incorrect, let us know.